Biotest Aktiengesellschaft (BIO3) — Cash Flow Quality Index
Biotest Aktiengesellschaft (BIO3) has a Cash Flow Quality Index of 6.02x as of June 2024. Operating cash flow of €58.40 Million exceeds net income of €9.70 Million, indicating high earnings quality where cash backs reported profits. Explore BIO3 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biotest Aktiengesellschaft Cash Flow Quality Index (2002–2024)
Historical Cash Flow Quality Index for Biotest Aktiengesellschaft across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see BIO3 cash flow conversion.
Annual Cash Flow Quality Index for Biotest Aktiengesellschaft (2002–2024)
Year-by-year earnings quality comparison for Biotest Aktiengesellschaft.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.31x | €60.90 Million | €26.40 Million | ▲ +10950.6% |
| 2023 | -0.02x | €-2.70 Million | €127.00 Million | ▲ +98.3% |
| 2022 | -1.28x | €-40.50 Million | €31.70 Million | ▼ -202.2% |
| 2016 | 1.25x | €65.90 Million | €52.70 Million | ▲ +614.4% |
| 2014 | -0.24x | €-11.40 Million | €46.90 Million | ▼ -61.4% |
| 2013 | -0.15x | €-7.20 Million | €47.80 Million | ▼ -115.8% |
| 2012 | 0.95x | €34.73 Million | €36.48 Million | ▼ -62.4% |
| 2011 | 2.53x | €72.28 Million | €28.58 Million | ▼ -7.5% |
| 2010 | 2.74x | €77.83 Million | €28.45 Million | ▲ +322.8% |
| 2009 | 0.65x | €31.68 Million | €48.97 Million | ▼ -24.0% |
| 2008 | 0.85x | €34.49 Million | €40.53 Million | ▼ -80.3% |
| 2004 | 4.32x | €25.29 Million | €5.85 Million | ▲ +37.2% |
| 2003 | 3.15x | €16.52 Million | €5.24 Million | ▲ +2433.7% |
| 2002 | 0.12x | €2.46 Million | €19.80 Million | — |